Morningstar Inc (MORN)
Official siteFINANCIAL SERVICES • FINANCIAL DATA & STOCK EXCHANGES • NASDAQ
Market Cap: $9.14B
Last updated: Nov 17, 2026 at 11:06 AM ET
Morningstar Inc (MORN) Stock Forecast
Analysts expect Morningstar (MORN) to earn $13.12 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.67B. Of 3 analysts, 2 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.33, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 67% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 2 | 66.7% |
| Hold | 1 | 33.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 14.0% and revenue estimates rise 6.0%.
- Fiscal year ending Dec 31, 2026
- $13.12
- EPS consensus, revenue $2.67B
- Fiscal year ending Dec 31, 2027
- $14.96
- EPS consensus, revenue $2.83B
- Next report
- Feb 10, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $13.12 | $13.02 to $13.21 | 3 | $2.67B | $2.67B to $2.68B | 3 |
| Dec 31, 2027 | $14.96 | $14.52 to $15.55 | 3 | $2.83B | $2.81B to $2.85B | 3 |
Quarterly Estimates
The EPS consensus rises from $3.18 for the quarter ending Dec 31, 2026 to $3.54 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $3.18 | $2.91 to $3.43 | 4 | $711.12M | $676.05M to $739.73M | 4 |
| Mar 31, 2027 | $3.54 | $3.54 to $3.54 | 1 | $687.40M | $687.40M to $687.40M | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 6 upward and 1 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 3 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 1 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 6.5% from $12.32.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $13.12 | $12.37 | $12.32 | $12.32 | $12.32 | +6.5% |
| Fiscal year ending Dec 31, 2027 | $14.96 | $14.00 | $13.94 | $13.94 | $13.94 | +7.3% |
| Quarter ending Mar 31, 2027 | $3.54 | $3.46 | $3.46 | $3.46 | $3.46 | +2.3% |
Frequently Asked Questions About MORN
What is the MORN stock forecast?
Consensus analyst estimates put Morningstar's EPS at $13.12 for the fiscal year ending Dec 31, 2026, on revenue of $2.67B. The consensus rating from 3 analysts is Buy.
How do analysts rate MORN stock?
Of 3 analysts covering Morningstar, 0 rate it Strong Buy, 2 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from MORN next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $13.12, with estimates from $13.02 to $13.21 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $14.96, with estimates from $14.52 to $15.55 from 3 analysts.
What revenue do analysts expect from Morningstar next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.67B, with estimates from $2.67B to $2.68B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.83B, with estimates from $2.81B to $2.85B.
How many analysts cover MORN?
3 analysts rate Morningstar stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
MORN pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts